Association of serum cytokines with coronary chronic total occlusion and their role in predicting procedural outcomes

Malakar, 2019, A review on coronary artery disease, its risk factors, and therapeutics, J Cell Physiol, 234, 16812, 10.1002/jcp.28350 Ybarra, 2021, Definitions and Clinical Trial Design Principles for Coronary Artery Chronic Total Occlusion Therapies: CTO-ARC Consensus Recommendations, Circulation, 143, 479, 10.1161/CIRCULATIONAHA.120.046754 Koelbl, 2018, Coronary Chronic Total Occlusion (CTO): A Review, Rev Cardiovasc Med, 19, 33, 10.31083/j.rcm.2018.01.896 Srivatsa, 1997, Histologic correlates of angiographic chronic total coronary artery occlusions: influence of occlusion duration on neovascular channel patterns and intimal plaque composition, J Am Coll Cardiol, 29, 955, 10.1016/S0735-1097(97)00035-1 Hoebers, 2014, Contemporary overview and clinical perspectives of chronic total occlusions, Nat Rev Cardiol, 11, 458, 10.1038/nrcardio.2014.74 Tedgui, 2006, Cytokines in atherosclerosis: pathogenic and regulatory pathways, Physiol Rev, 86, 515, 10.1152/physrev.00024.2005 Fatkhullina, 2016, The Role of Cytokines in the Development of Atherosclerosis, Biochemistry (Mosc), 81, 1358, 10.1134/S0006297916110134 Tsioufis, 2022, The Impact of Cytokines in Coronary Atherosclerotic Plaque: Current Therapeutic Approaches, Int J Mol Sci, 23, 10.3390/ijms232415937 Reed, 2017, Acute myocardial infarction, Lancet, 389, 197, 10.1016/S0140-6736(16)30677-8 Thygesen, 2018, Fourth Universal Definition of Myocardial Infarction (2018), Circulation, 138, e618, 10.1161/CIR.0000000000000617 Agrawal, 2020, Coronary Artery Disease, Arterioscler Thromb Vasc Biol, 40, e185, 10.1161/ATVBAHA.120.313608 Khatri, 2017, Management of coronary chronic total occlusion, Cleve Clin J Med, 84, 27, 10.3949/ccjm.84.s3.03 Azzalini, 2022, Contemporary Issues in Chronic Total Occlusion Percutaneous Coronary Intervention, JACC Cardiovasc Interv, 15, 1, 10.1016/j.jcin.2021.09.027 Assali, 2021, Update on chronic total occlusion percutaneous coronary intervention, Prog Cardiovasc Dis, 69, 27, 10.1016/j.pcad.2021.11.004 Liao, 2022, Revascularization of chronic total occlusion coronary artery and cardiac regeneration, Front Cardiovasc Med, 9, 10.3389/fcvm.2022.940808 Anderson, 2017, Acute Myocardial Infarction, N Engl J Med, 376, 2053, 10.1056/NEJMra1606915 Westman, 2016, Inflammation as a Driver of Adverse Left Ventricular Remodeling After Acute Myocardial Infarction, J Am Coll Cardiol, 67, 2050, 10.1016/j.jacc.2016.01.073 Kazimierczyk, 2019, The relationships among monocyte subsets, miRNAs and inflammatory cytokines in patients with acute myocardial infarction, Pharmacol Rep, 71, 73, 10.1016/j.pharep.2018.09.007 Li, 2020, Interplay of TNF-α, soluble TNF receptors and oxidative stress in coronary chronic total occlusion of the oldest patients with coronary heart disease, Cytokine, 125, 10.1016/j.cyto.2019.154836 Huber, 2001, T helper-cell phenotype regulates atherosclerosis in mice under conditions of mild hypercholesterolemia, Circulation, 103, 2610, 10.1161/01.CIR.103.21.2610 Thornhill, 1990, IL-4 increases human endothelial cell adhesiveness for T cells but not for neutrophils, J Immunol, 144, 3060, 10.4049/jimmunol.144.8.3060 King, 2007, Interleukin-4 does not influence development of hypercholesterolemia or angiotensin II-induced atherosclerotic lesions in mice, Am J Pathol, 171, 2040, 10.2353/ajpath.2007.060857 Ridker, 2021, Interleukin-6 Signaling and Anti-Interleukin-6 Therapeutics in Cardiovascular Disease, Circ Res, 128, 1728, 10.1161/CIRCRESAHA.121.319077 Schieffer, 2004, Impact of interleukin-6 on plaque development and morphology in experimental atherosclerosis, Circulation, 110, 3493, 10.1161/01.CIR.0000148135.08582.97 Zhang, 2012, Interleukin 6 destabilizes atherosclerotic plaques by downregulating prolyl-4-hydroxylase α1 via a mitogen-activated protein kinase and c-Jun pathway, Arch Biochem Biophys, 528, 127, 10.1016/j.abb.2012.09.007 Cao, 2020, Treating Inflammation Prior to Percutaneous Coronary Intervention: Does the Heart Care?, Circ Cardiovasc Interv, 13, 10.1161/CIRCINTERVENTIONS.120.009127 Mourouzis, 2020, Pro-inflammatory Cytokines in Acute Coronary Syndromes, Curr Pharmaceut Des, 26, 4624, 10.2174/1381612826666200413082353 Held, 2017, Inflammatory Biomarkers Interleukin-6 and C-Reactive Protein and Outcomes in Stable Coronary Heart Disease: Experiences From the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial, J Am Heart Assoc, 6 Fanola, 2017, Interleukin-6 and the Risk of Adverse Outcomes in Patients After an Acute Coronary Syndrome: Observations From the SOLID-TIMI 52 (Stabilization of Plaque Using Darapladib-Thrombolysis in Myocardial Infarction 52) Trial, J Am Heart Assoc, 6 Nicholls, 2008, Circulation, 118, 2506, 10.1161/CIRCULATIONAHA.108.790733 Kou, 2021, Relationship between neutrophils to HDL-C ratio and severity of coronary stenosis, BMC Cardiovasc Disord, 21, 127, 10.1186/s12872-020-01771-z George, 2014, Long-term follow-up of elective chronic total coronary occlusion angioplasty: analysis from the U.K. Central Cardiac Audit Database, J Am Coll Cardiol, 64, 235, 10.1016/j.jacc.2014.04.040